Zenas BioPharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	May '26 May 29, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Cap	1,162	1,978	342	-	-
Market Cap Growth	219.91%	477.98%	-	-	-
Enterprise Value	711.28	1,635	-8.26	0	0
Last Close Price	18.40	36.31	8.19	-	-
PS Ratio	-	197.84	68.46	-	-
PB Ratio	3.42	1.96	1.10	-	-
P/TBV Ratio	0.75	1.61	1.17	-	-
EV/Sales Ratio	-	163.54	-1.65	-	-
EV/EBITDA Ratio	-	-	0.05	-	-
EV/EBIT Ratio	-	-	0.05	-	-
EV/FCF Ratio	-	-	0.07	-	-
Debt / Equity Ratio	0.22	0.00	0.00	0.01	0.02
Net Debt / Equity Ratio	-0.38	-0.34	-1.12	0.25	0.34
Net Debt / EBITDA Ratio	1.07	0.89	2.14	1.51	0.86
Net Debt / FCF Ratio	2.14	1.98	2.92	1.84	1.00
Asset Turnover	-	0.03	0.02	0.70	0
Quick Ratio	11.73	5.48	6.12	2.44	2.59
Current Ratio	11.94	5.61	6.21	2.57	2.64
Return on Equity (ROE)	-38.80%	-57.24%	-93.22%	-101.22%	-249.54%
Return on Assets (ROA)	-74.74%	-101.64%	-75.01%	-51.62%	-102.17%
Return on Invested Capital (ROIC)	1666.74%	1311.77%	675.12%	251.83%	426.12%
Return on Capital Employed (ROCE)	-83.98%	-120.90%	-91.66%	-79.43%	-156.75%
Buyback Yield / Dilution	-107.16%	0.00%	97.00%	0.00%	-
Total Shareholder Return	-107.16%	0.00%	97.00%	0.00%	-

SEC Filings: 10-K · 10-Q